Shanghai Pharmaceuticals (601607): Shanghai Pharmaceuticals Group Co., Ltd. Announcement on the Correction of the 2019 A-Share Stock Option Incentive Plan in the First Quarter of 2022 on Self-Exercise Results and Share Changes- CFi.CN Zhongcai.com

Key Data Concepts:   

? These are the company names, stock quotes, topics, and entities related to this data.

300049 300568 China Securities China Shipbuilding Industry Group Power Citic Securities Dong Feng Electronic Technology Fujian Funeng Shanghai Pharmaceuticals Holding Shenzhen Senior Technology Material Xinjiang Sayram Modern Agriculture Accounting, Audit Stock Option Board Of Directors Pharmaceutical Financial, Business Service Market, Exchange Securities Medicine Records, Achievements Exercise, Fitness

Full Data

?
UNLOCK DATA
Subscribe & Access the Best Data and Intelligence on the Chinese Stock Markets

Join Now!

Need this critical market data?

Access thousands of market events, data points, and news articles!

Already have an account?
Login

Home » News » Shanghai Pharmaceuticals (601607): Shanghai Pharmaceuticals Group Co., Ltd. Announcement on the Correction of the 2019 A-Share Stock Option Incentive Plan in the First Quarter of 2022 on Self-Exercise Results and Share Changes- CFi.CN Zhongcai.com